aluates Reports

$ 0.0

Automative

Global Metastatic Colorectal Cancer Drug Market Insights, Forecast to 2030

Published Date: November 2024

Report Code: QYRE-Auto-24R12666

Global Metastatic Colorectal Cancer Drug Market Research Report 2023

BUY CHAPTERS

Global Metastatic Colorectal Cancer Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-24R12666

Report

November 2024

Pages:112

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Merck

Eli Lilly

Roche

Genentech Inc

Bristol–Myers Squibb

Bayer

Novartis

TEVA

Sanofi

Regeneron Pharmaceuticals

Taiho Pharmaceutical

Metastatic Colorectal Cancer Drug Market Size

The global Metastatic Colorectal Cancer Drug market is projected to grow from US$ 16640 million in 2024 to US$ 21300 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period.

Metastatic Colorectal Cancer Drug Market

Market Analysis and Insights: Global Metastatic Colorectal Cancer Drug Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Metastatic Colorectal Cancer Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Metastatic Colorectal Cancer Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Metastatic Colorectal Cancer Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Metastatic Colorectal Cancer Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Metastatic Colorectal Cancer Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Metastatic Colorectal Cancer Drug revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Metastatic Colorectal Cancer Drug Market Report

Report Metric	Details
Report Name	Metastatic Colorectal Cancer Drug Market
Accounted market size in 2024	US$ 16640 in million
Forecasted market size in 2030	US$ 21300 million
CAGR	4.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Chemotherapy Drug Targeted Drug
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Merck, Eli Lilly, Roche, Genentech, Bristol Myers Squibb, Bayer, Novartis, Teva, Sanofi, Regeneron Pharmaceuticals, Taiho Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Metastatic Colorectal Cancer Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metastatic Colorectal Cancer Drug revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Metastatic Colorectal Cancer Drug Market growing?

Ans: The Metastatic Colorectal Cancer Drug Market witnessing a CAGR of 4.2 during the forecast period 2024-2030.

What is the Metastatic Colorectal Cancer Drug Market size in 2030?

Ans: The Metastatic Colorectal Cancer Drug Market size in 2030 will be US$ 21300 million.

Who are the main players in the Metastatic Colorectal Cancer Drug Market report?

Ans: The main players in the Metastatic Colorectal Cancer Drug Market are Pfizer, Merck, Eli Lilly, Roche, Genentech, Bristol Myers Squibb, Bayer, Novartis, Teva, Sanofi, Regeneron Pharmaceuticals, Taiho Pharmaceutical

What are the Application segmentation covered in the Metastatic Colorectal Cancer Drug Market report?

Ans: The Applications covered in the Metastatic Colorectal Cancer Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Metastatic Colorectal Cancer Drug Market report?

Ans: The Types covered in the Metastatic Colorectal Cancer Drug Market report are Chemotherapy Drug, Targeted Drug

Recommended Reports

Cancer Drug Therapies

Colorectal & GI Markets

Precision & Targeted Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Chemotherapy Drug

1.2.3 Targeted Drug

1.3 Market by Application

1.3.1 Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Colorectal Cancer Drug Market Perspective (2019-2030)

2.2 Global Metastatic Colorectal Cancer Drug Growth Trends by Region

2.2.1 Metastatic Colorectal Cancer Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Metastatic Colorectal Cancer Drug Historic Market Size by Region (2019-2024)

2.2.3 Metastatic Colorectal Cancer Drug Forecasted Market Size by Region (2025-2030)

2.3 Metastatic Colorectal Cancer Drug Market Dynamics

2.3.1 Metastatic Colorectal Cancer Drug Industry Trends

2.3.2 Metastatic Colorectal Cancer Drug Market Drivers

2.3.3 Metastatic Colorectal Cancer Drug Market Challenges

2.3.4 Metastatic Colorectal Cancer Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Metastatic Colorectal Cancer Drug by Players

3.1.1 Global Metastatic Colorectal Cancer Drug Revenue by Players (2019-2024)

3.1.2 Global Metastatic Colorectal Cancer Drug Revenue Market Share by Players (2019-2024)

3.2 Global Metastatic Colorectal Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Metastatic Colorectal Cancer Drug, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Metastatic Colorectal Cancer Drug Market Concentration Ratio

3.4.1 Global Metastatic Colorectal Cancer Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Colorectal Cancer Drug Revenue in 2023

3.5 Global Key Players of Metastatic Colorectal Cancer Drug Head office and Area Served

3.6 Global Key Players of Metastatic Colorectal Cancer Drug, Product and Application

3.7 Global Key Players of Metastatic Colorectal Cancer Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Colorectal Cancer Drug Breakdown Data by Type

4.1 Global Metastatic Colorectal Cancer Drug Historic Market Size by Type (2019-2024)

4.2 Global Metastatic Colorectal Cancer Drug Forecasted Market Size by Type (2025-2030)

5 Metastatic Colorectal Cancer Drug Breakdown Data by Application

5.1 Global Metastatic Colorectal Cancer Drug Historic Market Size by Application (2019-2024)

5.2 Global Metastatic Colorectal Cancer Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Metastatic Colorectal Cancer Drug Market Size (2019-2030)

6.2 North America Metastatic Colorectal Cancer Drug Market Size by Type

6.2.1 North America Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024)

6.2.2 North America Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030)

6.2.3 North America Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

6.3 North America Metastatic Colorectal Cancer Drug Market Size by Application

6.3.1 North America Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024)

6.3.2 North America Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030)

6.3.3 North America Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

6.4 North America Metastatic Colorectal Cancer Drug Market Size by Country

6.4.1 North America Metastatic Colorectal Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024)

6.4.3 North America Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Metastatic Colorectal Cancer Drug Market Size (2019-2030)

7.2 Europe Metastatic Colorectal Cancer Drug Market Size by Type

7.2.1 Europe Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024)

7.2.2 Europe Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030)

7.2.3 Europe Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

7.3 Europe Metastatic Colorectal Cancer Drug Market Size by Application

7.3.1 Europe Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024)

7.3.2 Europe Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030)

7.3.3 Europe Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

7.4 Europe Metastatic Colorectal Cancer Drug Market Size by Country

7.4.1 Europe Metastatic Colorectal Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024)

7.4.3 Europe Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Metastatic Colorectal Cancer Drug Market Size (2019-2030)

8.2 China Metastatic Colorectal Cancer Drug Market Size by Type

8.2.1 China Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024)

8.2.2 China Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030)

8.2.3 China Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

8.3 China Metastatic Colorectal Cancer Drug Market Size by Application

8.3.1 China Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024)

8.3.2 China Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030)

8.3.3 China Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Metastatic Colorectal Cancer Drug Market Size (2019-2030)

9.2 Asia Metastatic Colorectal Cancer Drug Market Size by Type

9.2.1 Asia Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024)

9.2.2 Asia Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030)

9.2.3 Asia Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

9.3 Asia Metastatic Colorectal Cancer Drug Market Size by Application

9.3.1 Asia Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024)

9.3.2 Asia Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030)

9.3.3 Asia Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

9.4 Asia Metastatic Colorectal Cancer Drug Market Size by Region

9.4.1 Asia Metastatic Colorectal Cancer Drug Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Metastatic Colorectal Cancer Drug Market Size by Region (2019-2024)

9.4.3 Asia Metastatic Colorectal Cancer Drug Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Type

10.2.1 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Application

10.3.1 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country

10.4.1 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Metastatic Colorectal Cancer Drug Introduction

11.1.4 Pfizer Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.1.5 Pfizer Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Metastatic Colorectal Cancer Drug Introduction

11.2.4 Merck Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.2.5 Merck Recent Developments

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Metastatic Colorectal Cancer Drug Introduction

11.3.4 Eli Lilly Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.3.5 Eli Lilly Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Metastatic Colorectal Cancer Drug Introduction

11.4.4 Roche Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.4.5 Roche Recent Developments

11.5 Genentech

11.5.1 Genentech Company Details

11.5.2 Genentech Business Overview

11.5.3 Genentech Metastatic Colorectal Cancer Drug Introduction

11.5.4 Genentech Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.5.5 Genentech Recent Developments

11.6 Bristol Myers Squibb

11.6.1 Bristol Myers Squibb Company Details

11.6.2 Bristol Myers Squibb Business Overview

11.6.3 Bristol Myers Squibb Metastatic Colorectal Cancer Drug Introduction

11.6.4 Bristol Myers Squibb Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.6.5 Bristol Myers Squibb Recent Developments

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Metastatic Colorectal Cancer Drug Introduction

11.7.4 Bayer Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.7.5 Bayer Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Metastatic Colorectal Cancer Drug Introduction

11.8.4 Novartis Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.8.5 Novartis Recent Developments

11.9 Teva

11.9.1 Teva Company Details

11.9.2 Teva Business Overview

11.9.3 Teva Metastatic Colorectal Cancer Drug Introduction

11.9.4 Teva Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.9.5 Teva Recent Developments

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Metastatic Colorectal Cancer Drug Introduction

11.10.4 Sanofi Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.10.5 Sanofi Recent Developments

11.11 Regeneron Pharmaceuticals

11.11.1 Regeneron Pharmaceuticals Company Details

11.11.2 Regeneron Pharmaceuticals Business Overview

11.11.3 Regeneron Pharmaceuticals Metastatic Colorectal Cancer Drug Introduction

11.11.4 Regeneron Pharmaceuticals Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.11.5 Regeneron Pharmaceuticals Recent Developments

11.12 Taiho Pharmaceutical

11.12.1 Taiho Pharmaceutical Company Details

11.12.2 Taiho Pharmaceutical Business Overview

11.12.3 Taiho Pharmaceutical Metastatic Colorectal Cancer Drug Introduction

11.12.4 Taiho Pharmaceutical Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024)

11.12.5 Taiho Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Merck

Eli Lilly

Roche

Genentech Inc

Bristol–Myers Squibb

Bayer

Novartis

TEVA

Sanofi

Regeneron Pharmaceuticals

Taiho Pharmaceutical

List of Tables

Table 1. Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Chemotherapy Drug

Table 3. Key Players of Targeted Drug

Table 4. Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Metastatic Colorectal Cancer Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Metastatic Colorectal Cancer Drug Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Metastatic Colorectal Cancer Drug Market Share by Region (2019-2024)

Table 8. Global Metastatic Colorectal Cancer Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Metastatic Colorectal Cancer Drug Market Share by Region (2025-2030)

Table 10. Metastatic Colorectal Cancer Drug Market Trends

Table 11. Metastatic Colorectal Cancer Drug Market Drivers

Table 12. Metastatic Colorectal Cancer Drug Market Challenges

Table 13. Metastatic Colorectal Cancer Drug Market Restraints

Table 14. Global Metastatic Colorectal Cancer Drug Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Metastatic Colorectal Cancer Drug Revenue Share by Players (2019-2024)

Table 16. Global Top Metastatic Colorectal Cancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Drug as of 2023)

Table 17. Global Metastatic Colorectal Cancer Drug Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Metastatic Colorectal Cancer Drug Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Metastatic Colorectal Cancer Drug, Headquarters and Area Served

Table 20. Global Key Players of Metastatic Colorectal Cancer Drug, Product and Application

Table 21. Global Key Players of Metastatic Colorectal Cancer Drug, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Metastatic Colorectal Cancer Drug Revenue Market Share by Type (2019-2024)

Table 25. Global Metastatic Colorectal Cancer Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Metastatic Colorectal Cancer Drug Revenue Market Share by Type (2025-2030)

Table 27. Global Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Metastatic Colorectal Cancer Drug Revenue Share by Application (2019-2024)

Table 29. Global Metastatic Colorectal Cancer Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Metastatic Colorectal Cancer Drug Revenue Share by Application (2025-2030)

Table 31. North America Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Metastatic Colorectal Cancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Metastatic Colorectal Cancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Metastatic Colorectal Cancer Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Metastatic Colorectal Cancer Drug Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Metastatic Colorectal Cancer Drug Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size by Country (2025-2030) & (US$ Million)

Table 63. Pfizer Company Details

Table 64. Pfizer Business Overview

Table 65. Pfizer Metastatic Colorectal Cancer Drug Product

Table 66. Pfizer Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 67. Pfizer Recent Developments

Table 68. Merck Company Details

Table 69. Merck Business Overview

Table 70. Merck Metastatic Colorectal Cancer Drug Product

Table 71. Merck Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Developments

Table 73. Eli Lilly Company Details

Table 74. Eli Lilly Business Overview

Table 75. Eli Lilly Metastatic Colorectal Cancer Drug Product

Table 76. Eli Lilly Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 77. Eli Lilly Recent Developments

Table 78. Roche Company Details

Table 79. Roche Business Overview

Table 80. Roche Metastatic Colorectal Cancer Drug Product

Table 81. Roche Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 82. Roche Recent Developments

Table 83. Genentech Company Details

Table 84. Genentech Business Overview

Table 85. Genentech Metastatic Colorectal Cancer Drug Product

Table 86. Genentech Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 87. Genentech Recent Developments

Table 88. Bristol Myers Squibb Company Details

Table 89. Bristol Myers Squibb Business Overview

Table 90. Bristol Myers Squibb Metastatic Colorectal Cancer Drug Product

Table 91. Bristol Myers Squibb Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 92. Bristol Myers Squibb Recent Developments

Table 93. Bayer Company Details

Table 94. Bayer Business Overview

Table 95. Bayer Metastatic Colorectal Cancer Drug Product

Table 96. Bayer Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 97. Bayer Recent Developments

Table 98. Novartis Company Details

Table 99. Novartis Business Overview

Table 100. Novartis Metastatic Colorectal Cancer Drug Product

Table 101. Novartis Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 102. Novartis Recent Developments

Table 103. Teva Company Details

Table 104. Teva Business Overview

Table 105. Teva Metastatic Colorectal Cancer Drug Product

Table 106. Teva Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 107. Teva Recent Developments

Table 108. Sanofi Company Details

Table 109. Sanofi Business Overview

Table 110. Sanofi Metastatic Colorectal Cancer Drug Product

Table 111. Sanofi Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 112. Sanofi Recent Developments

Table 113. Regeneron Pharmaceuticals Company Details

Table 114. Regeneron Pharmaceuticals Business Overview

Table 115. Regeneron Pharmaceuticals Metastatic Colorectal Cancer Drug Product

Table 116. Regeneron Pharmaceuticals Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 117. Regeneron Pharmaceuticals Recent Developments

Table 118. Taiho Pharmaceutical Company Details

Table 119. Taiho Pharmaceutical Business Overview

Table 120. Taiho Pharmaceutical Metastatic Colorectal Cancer Drug Product

Table 121. Taiho Pharmaceutical Revenue in Metastatic Colorectal Cancer Drug Business (2019-2024) & (US$ Million)

Table 122. Taiho Pharmaceutical Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Metastatic Colorectal Cancer Drug Market Share by Type: 2023 VS 2030

Figure 3. Chemotherapy Drug Features

Figure 4. Targeted Drug Features

Figure 5. Global Metastatic Colorectal Cancer Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Metastatic Colorectal Cancer Drug Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Metastatic Colorectal Cancer Drug Report Years Considered

Figure 11. Global Metastatic Colorectal Cancer Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Metastatic Colorectal Cancer Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Metastatic Colorectal Cancer Drug Market Share by Region: 2023 VS 2030

Figure 14. Global Metastatic Colorectal Cancer Drug Market Share by Players in 2023

Figure 15. Global Top Metastatic Colorectal Cancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Drug as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Metastatic Colorectal Cancer Drug Revenue in 2023

Figure 17. North America Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

Figure 19. North America Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

Figure 20. North America Metastatic Colorectal Cancer Drug Market Share by Country (2019-2030)

Figure 21. United States Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Metastatic Colorectal Cancer Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

Figure 25. Europe Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

Figure 26. Europe Metastatic Colorectal Cancer Drug Market Share by Country (2019-2030)

Figure 27. Germany Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Metastatic Colorectal Cancer Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

Figure 35. China Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

Figure 36. Asia Metastatic Colorectal Cancer Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

Figure 38. Asia Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

Figure 39. Asia Metastatic Colorectal Cancer Drug Market Share by Region (2019-2030)

Figure 40. Japan Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Metastatic Colorectal Cancer Drug Market Share by Country (2019-2030)

Figure 50. Brazil Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Metastatic Colorectal Cancer Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Pfizer Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 57. Merck Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 58. Eli Lilly Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 59. Roche Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 60. Genentech Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 61. Bristol Myers Squibb Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 62. Bayer Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 63. Novartis Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 64. Teva Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 65. Sanofi Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 66. Regeneron Pharmaceuticals Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 67. Taiho Pharmaceutical Revenue Growth Rate in Metastatic Colorectal Cancer Drug Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Colon Targeted Drug Delivery Systems Market Insights Forecast to 2030

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights Forecast to 2030

Global Atherosclerosis Drugs Market Insights Forecast to 2030

Global Drug Discovery Assays Market Insights Forecast to 2030

Global Osteoporosis Treatment Market Insights Forecast to 2030

Global Nasal Polyps Treatment Market Insights Forecast to 2030

Global Rheumatic Disorders Drug Market Insights Forecast to 2030

Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030

Global Angioedema Treatment Market Insights Forecast to 2030

Global Systemic Lupus Erythematosus Treatment Market Insights Forecast to 2030

Global Benign Prostatic Hyperplasia Treatment Market Insights Forecast to 2030

Global Systemic Inflammatory Response Syndrome Treatment Market Insights Forecast to 2030

Global Blood Pressure Disorders Drug Market Insights Forecast to 2030

Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030

Global Anti PD 1 MAb Market Insights Forecast to 2030

Global Photodynamic Therapy Market Insights Forecast to 2030

Global Patient Intake Software Market Insights Forecast to 2030

Global Breast Lesion Localization Market Insights Forecast to 2030

Global Gastroenterology EMR Software Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions